Additional information
White Powder
265989-44-4
ACI-011225
208.2-209.0°C
C33H34FN2NaO6
596.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
4-Hydroxy atorvastatin





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)